Market Overview The cancer cachexia market is targeting cytokine-driven muscle wasting through anti-inflammatory strategies addressing the inflammatory pathophysiology of cancer-related cachexia. The Cancer Cachexia Market is projected to grow through 2030, driven by IL-6 pathway inhibition, TNF-alpha blockade, and NF-kB modulation supporting preservation of muscle mass and metabolic...